Lisa Lupinacci

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta et al. · The Lancet Oncology · 2005 · 1.6K citations

Veterinary Medicine, Infectious Diseases, Oncology +17

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta et al. · British Journal of Cancer · 2006 · 808 citations · Full text

Medicine, Gynecology, Preventive Medicine +17

Ten year follow-up of healthy children who received one or two injections of varicella vaccine

Barbara J. Kuter, Holly Matthews, Henry R. Shinefield et al. · The Pediatric Infectious Disease Journal · 2004 · 384 citations

Medicine, Immunology, Pediatrics +17

Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine

Darron R. Brown, Kenneth H. Fife, Cosette M. Wheeler et al. · Vaccine · 2004 · 88 citations

Veterinary Medicine, Immunology, Infectious Diseases +16